Epidemiologic and clinical characteristics of heart transplant recipients during the 2019 coronavirus outbreak in Wuhan, China: A descriptive survey report

Journal of Heart and Lung Transplantation

Volumn 39, Issue 5, 2020, Pages 412-417

  Ren, Zong Li ^a   Hu, Rui ^a   Wang, Zhi Wei ^a   Zhang, Min ^a   Ruan, Yong Le ^a   Wu, Zhi Yong ^a   Wu, Hong Bing ^a   Hu, Xiao Ping ^a   Hu, Zhi Peng ^a   Ren, Wei ^a   Li, Luo Cheng ^a   Dai, Fei Feng ^a   Liu, Huan ^a   Cai, Xin ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

angiotensin converting enzyme 2; COVID 19; heart transplantation; immunosuppressive therapy; SARS CoV 2

Indexed keywords

TACROLIMUS; ANGIOTENSIN CONVERTING ENZYME 2; DIPEPTIDYL CARBOXYPEPTIDASE; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHINA; CORONAVIRUS DISEASE 2019; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; EPIDEMIC; FEMALE; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; KIDNEY FAILURE; LABORATORY TEST; LIVER FAILURE; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; ONLINE SYSTEM; PANDEMIC; PRIORITY JOURNAL; QUARANTINE; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; TRAVEL; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; WEB BROWSER; BETACORONAVIRUS; CORONAVIRINAE; CORONAVIRUS INFECTION; GENETICS; IMMUNOSUPPRESSIVE TREATMENT; ISOLATION AND PURIFICATION; MIDDLE AGED; VIRUS PNEUMONIA;

ADULT; BETACORONAVIRUS; CHINA; CORONAVIRUS; CORONAVIRUS INFECTIONS; DISEASE OUTBREAKS; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PANDEMICS; PEPTIDYL-DIPEPTIDASE A; PNEUMONIA, VIRAL; QUARANTINE; RETROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES;

EID: 85083591549     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2020.03.008     Document Type: Article

References (45)

1. Zhu, N, Zhang, D, Wang, W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382 (2020), 727–733.
2. Huang, C, Wang, Y, Li, X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395 (2020), 497–506.
3. Chen, N, Zhou, M, Dong, X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395 (2020), 507–513.
4. Zhou, P, Yang, XL, Wang, XG, et al. A pneumonia outbreak associatedwith a new coronavirus of probable bat origin. Nature 579 (2020), 270–273.
5. WHO>World Health Organization. Available at: https://www.who.int.
6. New coronavirus pneumonia prevention and control program in China. 5th ed, 2020 [in Chinese].
7. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China [e-pub ahead of print]. JAMA. doi: 10.1001/jama.2020.1585, Accessed February 25, 2020.
8. Shi, B, Current development of the organ transplantation in China, past and future. Organ Transpl 10 (2019), 32–35 [in Chinese].
9. Huang, J, Induction and maintenance of immunosuppression in heart transplantation. Chin Transpl J 12 (2018), 49–54 [in Chinese].
10. Peiris, JS, Lai, ST, Poon, LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361 (2003), 1319–1325.
11. Yeung, ML, Yao, Y, Jia, L, et al. MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2. Nat Microbiol, 1, 2016, 16004.
12. Hung, IF, Cheng, VC, Wu, AK, et al. Viral loads in clinical specimens and SARS manifestations. Emerg Infect Dis 10 (2004), 1550–1557.
13. Assiri, A, Al-Tawfiq, JA, Al-Rabeeah, AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 13 (2013), 752–761.
14. Rahman, A, Sarkar, A., Risk factors for fatal Middle East respiratory syndrome coronavirus infections in Saudi Arabia: analysis of the WHO line list, 2013-2018. Am J Public Health 109 (2019), 1288–1293.
15. Tu, Y, Wu, X, Liu, F, et al. A clinical report of 2 cases of renal transplant recipients with newly developed coronavirus pneumonia. Chin J Organ Transplant, 41, 2020, E005 [in Chinese].
16. Ju C, Li L, Qiu T, Xue W, Shi B. Clinical characteristics of novel coronavirus pneumonia in transplant recipients and management strategies during the outbreak. Anti-new coronary pneumonia column. 1st ed [in Chinese]. Available at: http://www.cotdf.org/index.php?m=content&c=index&a=show&catid=19&id=1144.
17. González, JM, Gomez-Puertas, P, Cavanagh, D, Gorbalenya, AE, Enjuanes, L, A comparative sequence analysis to revise the current taxonomy of the family Coronaviridae. Arch Virol 148 (2003), 2207–2235.
18. Weiss, SR, Navas-Martin, S, Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev 69 (2005), 635–664.
19. Wevers, BA, Hoek, Lvd, Renin–angiotensin system in human coronavirus pathogenesis. Future Virol 5 (2010), 145–161.
20. Kuba, K, Imai, Y, Rao, S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury. Nat Med 11 (2005), 875–879.
21. Li, W, Moore, MJ, Vasilieva, N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426 (2003), 450–454.
22. Xu, X, Chen, P, Wang, J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China. Life Sci 63 (2020), 457–460.
23. Xu, H, Zhong, L, Deng, J, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci, 12, 2020, 8.
24. Kurdi, M, De Mello, WC, Booz, GW, Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components. Int J Biochem Cell Biol 37 (2005), 1357–1367.
25. Gallagher, PE, Chappell, MC, Ferrario, CM, Tallant, EA, Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes. Am J Physiol Cell Physiol 290 (2006), C420–C426.
26. Letizia, C, D'Ambrosio, C, De Ciocchis, A, Scavo, D, Pozzilli, P, Serum angiotensin-converting enzyme levels in patients with recent-onset insulin-dependent diabetes after one year of low-dose cyclosporin therapy. IMDIAB study group. Int J Clin Pharmacol Res 15 (1995), 209–213.
27. Hošková, L, Málek, I, Kautzner, J, et al. Tacrolimus-induced hypertension and nephrotoxicity in Fawn-Hooded rats are attenuated by dual inhibition of renin-angiotensin system. Hypertens Res 37 (2014), 724–732.
28. Kupferman, JC, Beaudoin, R, Carr, R, et al. Activation of the renal renin-angiotensin system by cyclosporine A and FK 506 in the rat. Transplant Proc 26 (1994), 2891–2893.
29. Julien, J, Farge, D, Kreft-Jais, C, et al. Cyclosporine-induced stimulation of the renin-angiotensin system after liver and heart transplantation. Transplantation 56 (1993), 885–891.
30. Schreiber, SL, Crabtree, GR, The mechanism of action of cyclosporin A and FK506. Immunol Today 13 (1992), 136–142.
31. Ferrario, CM, Jessup, J, Chappell, MC, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 111 (2005), 2605–2610.
32. Zumla, A, Hui, DS, Azhar, EI, Memish, ZA, Maeurer, M, Reducing mortality from 2019-nCoV: host-directed therapies should be an option. Lancet 395 (2020), e35–e36.
33. Xu, Z, Shi, L, Wang, Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome [e-pub ahead of print]. Lancet Respir Med, 2020, 10.1016/S2213-2600(20)30076-X Accessed February 25, 2020.
34. Nicholls, JM, Poon, LL, Lee, KC, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 361 (2003), 1773–1778.
35. Liu, J, Farmer, JD Jr, Lane, WS, Friedman, J, Weissman, I, Schreiber, SL, Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66 (1991), 807–815.
36. Liu, J, Albers, MW, Wandless, TJ, et al. Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry 31 (1992), 3896–3901.
37. Eugui, EM, Almquist, SJ, Muller, CD, Allison, AC, Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion. Scand J Immunol 33 (1991), 161–173.
38. Blaheta, RA, Leckel, K, Wittig, B, et al. Mycophenolate mofetil impairs transendothelial migration of allogeneic CD4 and CD8 T-cells. Transplant Proc 31 (1999), 1250–1252.
39. Takahira, R, Yonemura, K, Fujise, Y, Hishida, A, Dexamethasone attenuates neutrophil infiltration in the rat kidney in ischemia/reperfusion injury: the possible role of nitroxyl. Free Radic Biol Med 31 (2001), 809–815.
40. Abe, M, Thomson, AW, Dexamethasone preferentially suppresses plasmacytoid dendritic cell differentiation and enhances their apoptotic death. Clin Immunol 118 (2006), 300–306.
41. Ehrchen, J, Steinmüller, L, Barczyk, K, et al. Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood 109 (2007), 1265–1274.
42. Suda, T, Chida, K, Matsuda, H, et al. High-dose intravenous glucocorticoid therapy abrogates circulating dendritic cells. J Allergy Clin Immunol 112 (2003), 1237–1239.
43. Cupic, B, Breljak, D, Gabrilovac, J, Receptor-mediated down-regulation of neutral endopeptidase (NEP; EC 3.4.24.11; CD10) on immature B lymphocytes by dexamethasone. Int J Mol Med 15 (2005), 1023–1031.
44. Youinou, P, Pers, JO, The late news on BAFF in autoimmune diseases. Autoimmun Rev 9 (2010), 804–806.
45. Harr, MW, Rong, Y, Bootman, MD, Roderick, HL, Distelhorst, CW, Glucocorticoid-mediated inhibition of Lck modulates the pattern of T cell receptor-induced calcium signals by down-regulating inositol 1,4,5-trisphosphate receptors. J Biol Chem 284 (2009), 31860–31871.